Life sciences companies provide essential treatments and medical innovation to communities across the globe. Science and research are essential to their enterprise core. But so is growing the business. It’s this dichotomy, the pull of science and business, that often creates the greatest conflict and challenge for many life sciences businesses. Where should resources be focused? What are the business priorities? What must be positioned for longer-term considerations?
From financial and fundraising issues to addressing ongoing compliance needs or system efficiencies, companies in the biopharmaceutical, medtech and other businesses that serve the life sciences sector are challenged with meeting continuous business objectives and needs, while also being mindful of profitability and growth.
Our life sciences consulting team understands this dilemma. From pre-clinical to commercialization we work with clients through their entire business growth journey to help companies stay focused on their scientific innovations and clinical research while also working toward meaningful business growth.
Our professionals work with a variety of organizations, from startups to well-known businesses in the pharmaceutical and biotechnology space. Our responsive and custom consulting services assist you on your commercialization journey through complex regulatory problems, cost concerns, emerging risks and more.
Whether managing security and privacy risks, supply chain challenges, pricing pressures and value-based outcomes to global regulation complexities, we can assist your business with medtech consulting services.
Our life sciences advisors bring insight to help CROs, CMOs and others in the life sciences sector manage risk, address challenges, create efficiencies and elevate opportunities.
Tatyana Kosheleva, Chief Financial Officer, Amring Pharmaceuticals
Robin Grimwood, Co-founder and CEO, Sampled
James Murphy, Vice president of finance and controller, Sigilon Therapeutics Inc.